v3.26.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING AND NON-RECURRING BASIS

The following table provides a summary of financial assets and liabilities measured at fair value on a recurring and non-recurring basis (in thousands):

 

Description 

Fair Value at

March 31,

2026

   Level 1   Level 2   Level 3 
                 
Recurring Assets                    
Cash equivalents                    
Money market funds  $60,221   $60,221   $   $ 
Money market deposit account   182    182         
Short-term investments                    
U.S. treasury securities   20,038    20,038         
U.S. federal agency securities   17,866        17,866     
Certificates of deposit   68,993        68,993     
Total assets measured at fair value  $167,300   $80,441   $86,859   $ 
                     
Liabilities                    
Warrant liabilities  $13,516   $   $   $13,516 
Total liabilities measured at fair value  $13,516   $   $   $13,516 

 

Description  Fair Value at
December 31,
2025
   Level 1   Level 2   Level 3 
                 
Recurring Assets                    
Cash equivalents                    
Money market funds  $73,854   $73,854   $   $ 
Money market deposit account   182    182         
Short-term investments                    
U.S. treasury securities   25,088    25,088         
U.S. federal agency securities   17,774        17,774     
Certificates of deposit   70,105        70,105     
Total assets measured at fair value  $187,003   $99,124   $87,879   $ 
                     
Liabilities                    
Warrant liabilities  $18,902   $   $   $18,902 
Total liabilities measured at fair value  $18,902   $   $   $18,902 
SCHEDULE OF OUTSTANDING WARRANT LIABILITIES

As of March 31, 2026 and December 31, 2025, the Company had the following outstanding warrants that are classified as liabilities:

 

   March 31, 2026   December 31, 2025 
         
Warrants issued as part of the 2021 public offering, expiration date December 2026, exercise price of $9.75 per share   1,788,000    1,788,000 
Warrants issued as part of the 2022 Private Placement Offering, expiration date November 2027, exercise price $4.75 per share   5,762,053    5,762,503 
Warrants issued as part of the 2024 Loan Agreement, expiration date January 2029, exercise price $4.07 per share   589,681    589,681 
Warrants issued as part of the 2024 Loan Agreement Amendment, expiration date July 2030, exercise price $6.07 per share   16,474    16,474 
SCHEDULE OF ACTIVITY OF WARRANT LIABILITIES

The following table provides a summary of the activity on the warrant liabilities (in thousands):

 

      
Warrant liabilities as of December 31, 2025  $18,902 
Issuance of warrants    
Gain recognized in earnings from change in fair value   (5,386)
Warrant liabilities as of March 31, 2026  $13,516 
SCHEDULE OF ESTIMATE FAIR VALUE OF WARRANTS

The following table outlines the key inputs for the Black-Scholes option-pricing model:

 

   March 31, 2026  December 31, 2025
       
Common share price  $4.48  $5.27
Expected term (years)   0.714.30   0.964.54
Risk-free interest rate (%)   3.64% – 3.81%   3.41% – 3.63%
Volatility (%)   77.10% – 100.00%   78.97% – 100.00%
Expected dividend yield (%)   0%   0%